Brief: Relmada Therapeutics Reports Qtrly Loss Per Share $1.33
11/08/2022 21:43
Aug 11 (Reuters) - Relmada Therapeutics Inc RLMD.O :
* RELMADA THERAPEUTICS PROVIDES CORPORATE UPDATE AND REPORTS
SECOND QUARTER 2022 FINANCIAL RESULTS
* RELMADA THERAPEUTICS INC - QTRLY LOSS PER SHARE $1.33
Source text for Eikon: ID:nPn11yRQ3a
Further company coverage: RLMD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Relmada Therapeutics
See all newsRelmada Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Relmada Therapeutics Q2 EPS USD -0.11
Relmada Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia As Chief Business Officer
Brief: Relmada Therapeutics - Increases Authorized Common Stock To 200 Million Shares From 150 Million